Pig and herd level prevalence of Toxoplasma gondii in Ontario finisher pigs in 2001, 2003, and 2004.
The objective of this study was to estimate the apparent and true prevalence of exposure to Toxoplasma gondii in Ontario finisher pigs. During the study period (2001 to 2004), sera from 6048 pigs were tested with a commercial enzyme-linked immunosorbent assay (ELISA); 103 farms were included 1 to 3 times in the study. True prevalence was estimated using a Bayesian approach. Apparent prevalence at the pig level was 1.59% [95% confidence interval (CI): 0.45, 2.99] in 2001, 0.06% (95% CI: 0.00, 0.46) in 2003, and 0.26% (95% CI: 0.00, 0.82) in 2004. Apparent prevalence at the herd-level was 13.7% (95% CI: 7.5, 22.3) in 2001; 1.25% (95% CI: 0.03, 6.77) in 2003, and 3.75% (95% CI: 0.78, 10.6) in 2004. Similarly, posterior Bayesian estimates of true prevalence at the pig level were 1.7% [95% probability interval (PI): 1.2, 2.2] in 2001, 0.2% (95% PI: 0.04, 0.4) in 2003, and 0.3% (95% PI: 0.1, 0.7) in 2004. At the herd level, posterior estimates of prevalence were 11.6% (95% PI: 7.4, 16.8) in 2001, 0% (95% PI: 0.0, 2.5) in 2003, and 1.2% (95% PI: 0.0, 5.0) in 2004 when a herd cut-point > or = 1 was used. Exposure to T. gondii in finishing pig farms in Ontario appears to be infrequent.
Poljak
Zvonimir
Z
Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1. zpoljak@uoguelph.ca
Dewey
Catherine E
CE
Friendship
Robert M
RM
Martin
S Wayne
SW
Christensen
Jette
J
Ojkic
Davor
D
Wu
John
J
Chow
Eva
E
D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood*; D001499:Bayes Theorem; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods / Q000662:veterinary; D005260:Female; D008297:Male; D009864:Ontario / Q000453:epidemiology; D018571:Sentinel Surveillance / Q000662:veterinary; D016036:Seroepidemiologic Studies; D013553:Swine Diseases / Q000453:epidemiology* / Q000469:parasitology; D014122:Toxoplasma / Q000276:immunology*; D014124:Toxoplasmosis, Animal / Q000453:epidemiology* / Q000469:parasitology
D000913:Antibodies, Protozoan
Am J Vet Res. 1995 Aug;56(8):1030-6
8533974
Prev Vet Med. 1998 Feb 6;34(1):19-30
9541948
Prim Care Update Ob Gyns. 2001 May;8(3):122-126
11378431
J Parasitol. 1995 Jun;81(3):410-5
7776126
Br Vet J. 1972 Jul;128(7):33-6
5049479
J Parasitol. 1998 Aug;84(4):759-63
9714207
Prev Vet Med. 2000 May 30;45(1-2):61-81
10802334
Emerg Infect Dis. 1999 Sep-Oct;5(5):607-25
10511517
Clin Infect Dis. 2002 Jan 1;34(1):103-15
11731953
Am J Epidemiol. 2001 Aug 15;154(4):357-65
11495859
Can J Vet Res. 1991 Oct;55(4):380-1
1790495
Int J Parasitol. 2000 Nov;30(12-13):1217-58
11113252
J Am Vet Med Assoc. 1995 Jun 1;206(11):1747-51
7782249
Prev Vet Med. 2004 Jun 10;64(1):1-14
15219965
J Parasitol. 1995 Oct;81(5):736-41
7472865
J Parasitol. 1998 Aug;84(4):862-5
9714227
Vet Parasitol. 2005 Mar 31;128(3-4):177-81
15740853
Am J Vet Res. 1990 Aug;51(8):1295-9
2386331
Vet Pathol. 1974;11(4):350-79
4460329
Prev Vet Med. 2003 Sep 12;60(4):281-95
12941553
Stat Med. 1999 Nov 30;18(22):3059-73
10544306
Scand J Infect Dis. 2002;34(5):362-5
12069021
Prev Vet Med. 1999 Mar 29;39(2):81-92
10223313
Vet Q. 1995 Sep;17(3):87-91
8525601
J Parasitol. 1989 Oct;75(5):750-5
2795377